Deciphera Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 83 rows in 2024. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2024-06-11: Reporting owner Sherman Matthew L; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-06-11: Reporting owner Sherman Matthew L; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-06-11: Reporting owner Sherman Matthew L; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-06-11: Reporting owner Sherman Matthew L; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-06-11 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −82,265 0 owned after | $9.23 exercise price | 2024-06-11 | |
| 2024-06-11 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −82,000 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −65,900 0 owned after | $15.48 exercise price | 2024-06-11 | |
| 2024-06-11 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −69,100 0 owned after | $15.92 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −85,456 0 owned after | $1.89 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,650 0 owned after | $3.95 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −103,219 0 owned after | $6.13 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −82,265 0 owned after | $9.23 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −82,000 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −65,900 0 owned after | $15.48 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −69,100 0 owned after | $15.92 exercise price | 2024-06-11 | |
| 2024-06-11 | Pitman Jama Officer (SVP, Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,531 0 owned after | $6.13 exercise price | 2024-06-11 | |
| 2024-06-11 | Pitman Jama Officer (SVP, Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,711 0 owned after | $17.00 exercise price | 2024-06-11 | |
| 2024-06-11 | Pitman Jama Officer (SVP, Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −62,971 0 owned after | $9.23 exercise price | 2024-06-11 | |
| 2024-06-11 | Pitman Jama Officer (SVP, Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −54,667 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Pitman Jama Officer (SVP, Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −44,600 0 owned after | $15.48 exercise price | 2024-06-11 | |
| 2024-06-11 | Pitman Jama Officer (SVP, Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,900 0 owned after | $15.92 exercise price | 2024-06-11 | |
| 2024-06-11 | Friedman Franklin Stuart Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,570 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Friedman Franklin Stuart Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,500 0 owned after | $13.98 exercise price | 2024-06-11 | |
| 2024-06-11 | Friedman Franklin Stuart Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,269 0 owned after | $21.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Friedman Franklin Stuart Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $14.91 exercise price | 2024-06-11 | |
| 2024-06-11 | Friedman Franklin Stuart Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,727 0 owned after | $14.46 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelley Susan L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,000 0 owned after | $22.49 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelley Susan L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,570 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelley Susan L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,500 0 owned after | $13.98 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelley Susan L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,269 0 owned after | $21.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Kelley Susan L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $14.91 exercise price | 2024-06-11 | |
| 2024-06-11 | Dhanak Dashyant Officer (EVP & Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −65,900 0 owned after | $13.42 exercise price | 2024-06-11 | |
| 2024-06-11 | Dhanak Dashyant Officer (EVP & Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −69,100 0 owned after | $15.92 exercise price | 2024-06-11 | |
| 2024-06-11 | Martin John Richard Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −52,000 0 owned after | $17.00 exercise price | 2024-06-11 | |
| 2024-06-11 | Martin John Richard Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $21.05 exercise price | 2024-06-11 | |
| 2024-06-11 | Martin John Richard Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,500 0 owned after | $13.98 exercise price | 2024-06-11 | |
| 2024-06-11 | Martin John Richard Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $14.91 exercise price | 2024-06-11 | |
| 2024-06-11 | Martin Daniel C. Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −62,971 0 owned after | $9.23 exercise price | 2024-06-11 | |
| 2024-06-11 | Martin Daniel C. Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −54,667 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Martin Daniel C. Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −44,600 0 owned after | $15.48 exercise price | 2024-06-11 | |
| 2024-06-11 | Martin Daniel C. Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,900 0 owned after | $15.92 exercise price | 2024-06-11 | |
| 2024-06-11 | Walsh Dennis Leo Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −52,000 0 owned after | $17.00 exercise price | 2024-06-11 | |
| 2024-06-11 | Walsh Dennis Leo Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $21.05 exercise price | 2024-06-11 | |
| 2024-06-11 | Walsh Dennis Leo Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,570 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Walsh Dennis Leo Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,500 0 owned after | $13.98 exercise price | 2024-06-11 | |
| 2024-06-11 | Walsh Dennis Leo Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,269 0 owned after | $21.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Walsh Dennis Leo Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $14.91 exercise price | 2024-06-11 | |
| 2024-06-11 | Walsh Dennis Leo Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,727 0 owned after | $14.46 exercise price | 2024-06-11 | |
| 2024-06-11 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Bristol Survivor's Trust | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −22,150 0 owned after | $3.95 exercise price | 2024-06-11 | |
| 2024-06-11 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Bristol Survivor's Trust | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −67,494 0 owned after | $6.13 exercise price | 2024-06-11 | |
| 2024-06-11 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Bristol Survivor's Trust | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $21.05 exercise price | 2024-06-11 | |
| 2024-06-11 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Bristol Survivor's Trust | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,570 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Bristol Survivor's Trust | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,500 0 owned after | $13.98 exercise price | 2024-06-11 | |
| 2024-06-11 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Bristol Survivor's Trust | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $14.91 exercise price | 2024-06-11 | |
| 2024-06-11 | Squarer Ron Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,570 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Squarer Ron Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,500 0 owned after | $13.98 exercise price | 2024-06-11 | |
| 2024-06-11 | Squarer Ron Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,269 0 owned after | $21.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Squarer Ron Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $14.91 exercise price | 2024-06-11 | |
| 2024-06-11 | Squarer Ron Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,727 0 owned after | $14.46 exercise price | 2024-06-11 | |
| 2024-06-11 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,233 0 owned after | $3.95 exercise price | 2024-06-11 | |
| 2024-06-11 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,181 0 owned after | $6.13 exercise price | 2024-06-11 | |
| 2024-06-11 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $21.05 exercise price | 2024-06-11 | |
| 2024-06-11 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,570 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,500 0 owned after | $13.98 exercise price | 2024-06-11 | |
| 2024-06-11 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,269 0 owned after | $21.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $14.91 exercise price | 2024-06-11 | |
| 2024-06-11 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,727 0 owned after | $14.46 exercise price | 2024-06-11 | |
| 2024-06-11 | Hoerter Steven L. Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −395,735 0 owned after | $25.40 exercise price | 2024-06-11 | |
| 2024-06-11 | Hoerter Steven L. Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −270,357 0 owned after | $9.23 exercise price | 2024-06-11 | |
| 2024-06-11 | Hoerter Steven L. Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −415,000 0 owned after | $8.27 exercise price | 2024-06-11 | |
| 2024-06-11 | Hoerter Steven L. Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −250,000 0 owned after | $15.48 exercise price | 2024-06-11 | |
| 2024-06-11 | Hoerter Steven L. Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −298,100 0 owned after | $15.92 exercise price | 2024-06-11 | |
| 2024-06-11 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,233 0 owned after | $3.95 exercise price | 2024-06-11 | |
| 2024-06-11 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,181 0 owned after | $6.13 exercise price | 2024-06-11 | |
| 2024-06-11 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $21.05 exercise price | 2024-06-11 | |
| 2024-06-11 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,500 0 owned after | $13.98 exercise price | 2024-06-11 | |
| 2024-06-11 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $14.91 exercise price | 2024-06-11 | |
| 2024-02-15 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,100 69,100 owned after | $15.92 exercise price | 2024-02-20 | |
| 2024-02-15 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,100 69,100 owned after | $15.92 exercise price | 2024-02-20 | |
| 2024-02-15 | Pitman Jama Officer (SVP, Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,900 38,900 owned after | $15.92 exercise price | 2024-02-20 | |
| 2024-02-15 | Hoerter Steven L. Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +298,100 298,100 owned after | $15.92 exercise price | 2024-02-20 | |
| 2024-02-15 | Dhanak Dashyant Officer (EVP & Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,100 69,100 owned after | $15.92 exercise price | 2024-02-20 | |
| 2024-02-15 | Martin Daniel C. Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,900 38,900 owned after | $15.92 exercise price | 2024-02-20 | |
| 2024-01-16 | Walsh Dennis Leo Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,727 4,727 owned after | $10.58 | 2024-01-18 | |
| 2024-01-16 | Friedman Franklin Stuart Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,727 4,727 owned after | $10.58 | 2024-01-18 | |
| 2024-01-16 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,727 4,727 owned after | $10.58 | 2024-01-18 | |
| 2024-01-16 | Squarer Ron Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,727 4,727 owned after | $10.58 | 2024-01-18 |